AIMS/HYPOTHESIS: The aim of this study was to examine the association of physical activity (PA) with all-cause mortality and incident and prevalent cardiovascular disease (CVD) among patients with type 1 diabetes. METHODS: The EURODIAB Prospective Complications Study is a cohort including 3,250 male and female patients with type 1 diabetes (mean age 32.7 ± 10.2 years) from 16 European countries, of whom 1,880 participated in follow-up examinations. In analysis 1 (longitudinal), the association of baseline PA (based on the reported number of hours per week spent in mild, moderate and vigorous PA) with all-cause mortality and incident CVD was examined by performing survival analysis. In analysis 2 (cross-sectional), we focused on the association between PA at follow-up (data on sports, walking distance and regular bicycling) and prevalent CVD by performing logistic regression analysis. Adjustments were made for age, sex, BMI, smoking, consumption of alcohol, consumption of certain nutrients and diabetic complications. RESULTS: Analysis 1 (longitudinal): participation in moderate or vigorous PA once a week or more was borderline inversely associated with all-cause mortality (men and women combined) (HR 0.66, 95% CI 0.42, 1.03) and incident CVD (women only) (HR 0.66, 95% CI 0.40, 1.08). No association was found in men. Analysis 2 (cross-sectional): total PA (indexed by sports, walking, bicycling) and distance walked were inversely associated with prevalent CVD (OR(totalPA) 0.66, 95% CI 0.45, 0.97; and OR(walking) 0.61, 95% CI 0.42, 0.89). CONCLUSIONS/ INTERPRETATION: PA showed a borderline inverse association with both all-cause mortality (both sexes) and incident CVD (women only) in patients with type 1 diabetes. Since this is an under-researched clinical population, future longitudinal studies with objective PA measurements are needed to expand on these results.
AIMS/HYPOTHESIS: The aim of this study was to examine the association of physical activity (PA) with all-cause mortality and incident and prevalent cardiovascular disease (CVD) among patients with type 1 diabetes. METHODS: The EURODIAB Prospective Complications Study is a cohort including 3,250 male and female patients with type 1 diabetes (mean age 32.7 ± 10.2 years) from 16 European countries, of whom 1,880 participated in follow-up examinations. In analysis 1 (longitudinal), the association of baseline PA (based on the reported number of hours per week spent in mild, moderate and vigorous PA) with all-cause mortality and incident CVD was examined by performing survival analysis. In analysis 2 (cross-sectional), we focused on the association between PA at follow-up (data on sports, walking distance and regular bicycling) and prevalent CVD by performing logistic regression analysis. Adjustments were made for age, sex, BMI, smoking, consumption of alcohol, consumption of certain nutrients and diabetic complications. RESULTS: Analysis 1 (longitudinal): participation in moderate or vigorous PA once a week or more was borderline inversely associated with all-cause mortality (men and women combined) (HR 0.66, 95% CI 0.42, 1.03) and incident CVD (women only) (HR 0.66, 95% CI 0.40, 1.08). No association was found in men. Analysis 2 (cross-sectional): total PA (indexed by sports, walking, bicycling) and distance walked were inversely associated with prevalent CVD (OR(totalPA) 0.66, 95% CI 0.45, 0.97; and OR(walking) 0.61, 95% CI 0.42, 0.89). CONCLUSIONS/ INTERPRETATION: PA showed a borderline inverse association with both all-cause mortality (both sexes) and incident CVD (women only) in patients with type 1 diabetes. Since this is an under-researched clinical population, future longitudinal studies with objective PA measurements are needed to expand on these results.
Authors: J I Mann; I De Leeuw; K Hermansen; B Karamanos; B Karlström; N Katsilambros; G Riccardi; A A Rivellese; S Rizkalla; G Slama; M Toeller; M Uusitupa; B Vessby Journal: Nutr Metab Cardiovasc Dis Date: 2004-12 Impact factor: 4.222
Authors: V A Koivisto; L K Stevens; M Mattock; P Ebeling; M Muggeo; J Stephenson; B Idzior-Walus Journal: Diabetes Care Date: 1996-07 Impact factor: 19.112
Authors: S N Balk; D A J M Schoenaker; G D Mishra; M Toeller; N Chaturvedi; J H Fuller; S S Soedamah-Muthu Journal: Eur J Clin Nutr Date: 2015-07-15 Impact factor: 4.016
Authors: Sabita S Soedamah-Muthu; Yvonne Vergouwe; Tina Costacou; Rachel G Miller; Janice Zgibor; Nish Chaturvedi; Janet K Snell-Bergeon; David M Maahs; Marian Rewers; Carol Forsblom; Valma Harjutsalo; Per-Henrik Groop; John H Fuller; Karel G M Moons; Trevor J Orchard Journal: Diabetologia Date: 2014-09-04 Impact factor: 10.122
Authors: Heidi Tikkanen-Dolenc; Johan Wadén; Carol Forsblom; Valma Harjutsalo; Lena M Thorn; Markku Saraheimo; Nina Elonen; Milla Rosengård-Bärlund; Daniel Gordin; Heikki O Tikkanen; Per-Henrik Groop Journal: Diabetologia Date: 2016-12-24 Impact factor: 10.122
Authors: Antonio Alberto Lopes; Brett Lantz; Hal Morgenstern; Mia Wang; Brian A Bieber; Brenda W Gillespie; Yun Li; Patricia Painter; Stefan H Jacobson; Hugh C Rayner; Donna L Mapes; Raymond C Vanholder; Takeshi Hasegawa; Bruce M Robinson; Ronald L Pisoni Journal: Clin J Am Soc Nephrol Date: 2014-10-02 Impact factor: 8.237